EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microencapsulated Sodium Butyrate Alleviates Immune Injury and Intestinal Problems Caused by Clostridium Perfringens through Gut Microbiota

Ting Yang iD, Yaowei Sun, Zhenglie Dai iD, Jinsong Liu, Shiping Xiao, Yulan Liu iD, Xiuxi Wang, Shenglan Yang, Ruiqiang Zhang iD, Caimei Yang, Bing Dai

Animals · 08.12.2023 · 13 (24) · 3784

DOI: 10.3390/ani13243784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animals, online erschienen am 08.12.2023. Verfasst von Ting Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, College of Veterinary Medicine, Key Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry …. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leading Innovation and Entrepreneurship Team Project of Zhejiang Province, Zhejiang Provincial Key R&D Program of China, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microencapsulated sodium butyrate (MS-SB) is an effective sodium butyrate additive which can reduce the release of sodium butyrate (SB) in the fore gastrointestinal tract. In this study, we assess the protective effects and mechanisms of MS-SB in Clostridium perfringens (C. perfringens)-challenged broilers. Broiler chickens were pre-treated with SB or MS-SB for 56 days and then challenged with C. perfringens three times. Our results indicate that the addition of MS-SB or SB before C. perfringens infection significantly decreased the thymus index (p < 0.05). Serum IgA, IgY, and IgM concentrations were significantly increased (p < 0.05), while pro-inflammatory IL-1β, IL-6, and TNF-α were significantly decreased (p < 0.05) under MS-SB or SB supplementation. Compared with SB, MS-SB presented a stronger performance, with higher IgA content, as well as a lower IL-1β level when normal or C. perfringens-challenged. While C. perfringens challenge significantly decreased the villus height (p < 0.05), MS-SB or SB administration significantly increased the villus height and villus height/crypt depth (V/C ratio) (p < 0.05). Varying degrees of SB or MS-SB increased the concentrations of volatile fatty acids (VFAs) during C. perfringens challenge, where MS-SB presented a stronger performance, as evidenced by the higher content of isovaleric acid and valeric acid. Microbial analysis demonstrated that both SB or MS-SB addition and C. perfringens infection increase variation in the microbiota community. The results also indicate that the proportions of Bacteroides, Faecalibacterium, Clostridia, Ruminococcaceae, Alistipes, and Clostridia were significantly higher in the MS-SB addition group while, at same time, C. perfringens infection increased the abundance of Bacteroides and Alistipes. In summary, dietary supplementation with SB or MS-SB improves the immune status and morphology of intestinal villi, increases the production of VFAs, and modulates cecal microbiota in chickens challenged with C. perfringens. Moreover, MS-SB was more effective than SB with the same supplemental amount.

Schlagwörter

Stichwörter der Autor:innen

Clostridium perfringensbroiler chickencecum microfloraimmunitymicroencapsulated sodium butyrate

Autor:innen und Institutionen

  • College of Animal Science and Technology, College of Veterinary Medicine, Key Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry of Zhejiang Province, Zhejiang Provincial Engineering Laboratory for A…
  • Zhejiang Vegamax Biotechnology Co., Ltd., Huzhou 313300, China.

ORCID-Profile: Ting Yang, Zhenglie Dai, Yulan Liu, Ruiqiang Zhang

Förderung

  • Leading Innovation and Entrepreneurship Team Project of Zhejiang Province
  • Zhejiang Provincial Key R&D Program of China
  • Natural Science Foundation of China
  • Jiangxi Modern Agricultural Research Collaborative Innovation Project
  • Hangzhou Key Projects for Agricultural and Social Development
  • Zhejiang Provincial Key R&amp;D Program of China

Zitieren

APA

Yang, T., Sun, Y., Dai, Z., Liu, J., Xiao, S., Liu, Y., Wang, X., Yang, S., Zhang, R., Yang, C., & Dai, B. (2023). Microencapsulated Sodium Butyrate Alleviates Immune Injury and Intestinal Problems Caused by Clostridium Perfringens through Gut Microbiota. Animals, 13(24), 3784. https://doi.org/10.3390/ani13243784

Vancouver

Yang T, Sun Y, Dai Z, Liu J, Xiao S, Liu Y, et al. Microencapsulated Sodium Butyrate Alleviates Immune Injury and Intestinal Problems Caused by Clostridium Perfringens through Gut Microbiota. Animals. 2023;13(24):3784. doi:10.3390/ani13243784

BibTeX
@article{Yang2023,
  author = {Yang, Ting and Sun, Yaowei and Dai, Zhenglie and Liu, Jinsong and Xiao, Shiping and Liu, Yulan and Wang, Xiuxi and Yang, Shenglan and Zhang, Ruiqiang and Yang, Caimei and Dai, Bing},
  title = {Microencapsulated Sodium Butyrate Alleviates Immune Injury and Intestinal Problems Caused by Clostridium Perfringens through Gut Microbiota},
  journal = {Animals},
  year = {2023},
  volume = {13},
  number = {24},
  pages = {3784},
  doi = {10.3390/ani13243784}
}
Kostenlos starten →